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Abstract
Background: The asthma-related airway wall remodeling is associated i.a. with a damage of bronchial epithelium
and subepithelial fibrosis. Functional interactions between human bronchial epithelial cells and human bronchial
fibroblasts are known as the epithelial-mesenchymal trophic unit (EMTU) and are necessary for a proper functioning
of lung tissue. However, a high concentration of the transforming growth factor-β1 (TGF-β1) in the asthmatic
bronchi drives the structural disintegrity of epithelium with the epithelial-to-mesenchymal transition (EMT) of the
bronchial epithelial cells, and of subepithelial fibrosis with the fibroblast-to-myofibroblast transition (FMT) of the
bronchial fibroblasts. Since previous reports indicate different intrinsic properties of the human bronchial epithelial
cells and human bronchial fibroblasts which affect their EMT/FMT potential beetween cells derived from asthmatic
and non-asthmatic patients, cultured separatelly in vitro, we were interested to see whether corresponding effects
could be obtained in a co-culture of the bronchial epithelial cells and bronchial fibroblasts. In this study, we
investigate the effects of the TGF-β1 on the EMT markers of the bronchial epithelial cells cultured in the air-liquid-
interface and effectiveness of FMT in the bronchial fibroblast populations in the EMTU models.
Results: Our results show that the asthmatic co-cultures are more sensitive to the TGF-β1 than the non-asthmatic
ones, which is associated with a higher potential of the asthmatic bronchial cells for a profibrotic response,
analogously to be observed in '2D' cultures. They also indicate a noticeable impact of human bronchial epithelial
cells on the TGF-β1-induced FMT, stronger in the asthmatic bronchial fibroblast populations in comparison to the
non-asthmatic ones. Moreover, our results suggest the protective effects of fibroblasts on the structure of the TGF-
β1–exposed mucociliary differentiated bronchial epithelial cells and their EMT potential.
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Conclusions: Our data are the first to demonstrate a protective effect of the human bronchial fibroblasts on the
properties of the human bronchial epithelial cells, which suggests that intrinsic properties of not only epithelium
but also subepithelial fibroblasts affect a proper condition and function of the EMTU in both normal and asthmatic
individuals.
Keywords: Transforming growth factor-β1, Air-liquid interface, Human bronchial epithelium, Human bronchial
(myo)fibroblasts, Asthma, Epithelial-mesenchymal trophic unit
Background
Maintaining tissue homeostasis with normal physiology
of human airways depends on the proper cooperation
between different types of cells forming the respiratory
tracts (epithelial cells, fibroblasts, smooth muscle cells,
endothelial and immune cells). However, according to
the theory by Plopper and Evans [1], proximity of bron-
chial epithelium and subepithelial fibroblasts largely co-
ordinates the control of the airway microenvironment
during lung development as well as in the progression of
pathophysiological processes involving a tissue damage
and repair or regulation of inflammation [2]. Immediate
anatomical and functional interactions between airway
epithelial cells and fibroblasts are known as the
epithelial-mesenchymal trophic unit (EMTU) [1]). Alter-
ations in its functionality observed in many respiratory
disorders such as idiopathic pulmonary fibrosis (IPF), a
chronic obstructive pulmonary disease (COPD) or
asthma lead to multiplications of signals to uncontrolled
airway remodeling which causes irreversible changes and
permanent impairment of the respiratory function of
these patients [2–6].
Asthma is defined as a chronic heterogeneous disease
affecting around 235 million people and running usually
with airway inflammation [7]. In response to relatively
high chronic local concentrations of proinflammatory
and/or profibrotic cytokines including mainly the trans-
forming growth factor-β (TGF-β), the airway structural
cells undergo functional and phenotypic changes [8].
The TGF-β1-activated bronchial epithelium is disinte-
grated by down-regulation of tight junctions and under-
goes the epithelial-mesenchymal transition (EMT) in
which the epithelial markers (e.g. E-cadherin; CDH1) are
replaced by the mesenchymal ones (N-cadherin; CDH2)
[2, 9, 10]. The abnormally functioning epithelium ob-
served in asthma is also the source of secreted pro-
inflammatory/profibrotic cytokines affecting deeper parts
of airways [11]. The activated mesenchymal cells estab-
lish secretory feedback mechanisms and affect the airway
epithelium. Based on these observations Holgate created
a concept that the impairment of the barrier function of
the airway epithelium plays a central role in the progres-
sion of the airway remodeling and asthma symptoms
[12]. Comparative studies on the properties of the
pseudostratified bronchial epithelium isolated from asth-
matic (AS) and non-asthmatic (NA) individuals were
previously reported [13, 14]. However, the epithelium
derived from asthmatic donors is characterized by an en-
hanced expression of inflammatory- and remodeling-
related genes in comparison to the ones obtained from
non-asthmatic donors [13, 15]. These intrinsic properties
of the asthmatic airway epithelial cells affect the profi-
brogenic potential of the airway fibroblasts [16–19].
Longitudinal studies reveal that the subepithelial layer
containing airway fibroblasts is also effectively activated
by profibrotic cytokines, including the TGF-β1, to
phenotypic shifts into highly contractile myofibroblasts
(fibroblast-to-myofibroblast transition, FMT). These
cells are characterized by overexpression of α-smooth
muscle actin (α-SMA) incorporated into microfilament
bundles, and hypersecretion of the extracellular matrix
(ECM) proteins as tenascin C, collagens and fibronectin
[20]. The excessive secretory activity of myofibroblasts
leads to thickening of the subepithelial layer which ef-
fectively impairs the respiratory tract functions with its
enhanced contractility [8].
Although the concept of Holgate et al. indicating that
the bronchial airways remodeling is determined by the
properties of the epithelium through interactions within
the EMTU is commonly accepted, several reports de-
scribe remodeling that may take place without inflam-
mation or may precede inflammation [21, 22]. It
suggests that mesenchymal cells, especially bronchial fi-
broblasts, may play more important role in induction or
progression of remodeling than it was previously
thought. Our recent studies indicate that the bronchial
fibroblasts isolated from asthmatic patients reveal differ-
ent features than their non-asthmatic counterparts [23–
28]. Therefore, our present study aims to assess the ef-
fect of the human bronchial fibroblasts (HBFs) and their
intrinsic properties on the responsiveness of the human
bronchial epithelial cells (HBECs) to the TGF-β1 using
in vitro EMTU model. We investigated the integrity of
the epithelial layer and properties of differentiated
HBECs in the absence or presence of the TGF-β1 when
cultured alone or co-cultured with the HBFs, compatible
asthmatic (HBECs AS / HBFs AS, from the same pa-
tients) or non-asthmatic (NA/NA) or mixed (AS/NA or
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NA/AS) in vitro EMTU models, respectively. Since the
ALI-cultured pseudostratified human airway epithelium
contains several subpopulations of specialized epithelial
cells [14, 29], we analyzed the gene expression markers
of goblet (MUC5AC+), ciliated (DNAH9+) and basal cells
(P63+), and the expression of the selected EMT-related
genes such as mesenchymal markers CDH2 (N-cad-
herin), ACTA2, and EMT-related transcription factors
SNAI1 and SNAI2 in all experimental conditions.
Moreover, we also checked the effect of the HBECs
from AS and NA individuals on the properties and the
FMT potential of the HBFs cultured in the EMTU
model in relation to our previous reports indicating dif-
ferent properties of the HBFs AS and NA in standard
‘2D’ culture. In the EMTUs we analyzed the expression
of the TGF-β1-induced FMT-related genes such as
ACTA2 (encoding α-SMA, the main marker of myofi-
broblasts, TAGLN (encoding transgelin - a smooth
muscle marker and unique actin-binding protein in-
volved in asthma), FN1 (fibronectin – ECM protein im-
portant in subepithelial fibrosis in asthma) and TNC
(tenascin C – ECM protein, biomarker for asthma). We
also analyzed the protective effects of the HBFs on the
properties of the HBECs in the EMTU model.
Results
ALI medium does not change the profibrotic properties
of the TGF-β1-treated HBFs derived from asthmatics
Our longitudinal studies clearly show that populations of
the HBF from AS and NA cultured in identical condi-
tions in a serum-free medium display different features
affecting their sensitivity to the external TGF-β1 and
FMT potential [20, 28, 30]. In standard in vitro cultures
the HBFs AS in response to the TGF-β1 develop the
myofibroblastic phenotype characterized by a relatively
high level of α-SMA incorporated into stress fibers more
efficiently than the NA counterparts [23–25, 27, 28]. To
clarify whether this phenomenon is pronounced in the
EMTU model, firstly, we checked in this study if the
medium dedicated for the air-liquid-interface (ALI) and
EMTU cultures significantly affects the FMT potential of
the TGF-β1-treated HBFs. For this purpose, we deter-
mined the myofibroblast phenotype in the HBF popula-
tions, derived from both investigated groups, by
immunofluorescence and in-cell ELISA studies after 4
days of the HBFs culture in the serum-free medium with
high glucose (HG) or ALI-dedicated medium (ALI), in
the absence or presence of the TGF-β1. The obtained re-
sults indicated that the TGF-β1-treated HBFs from both
NA and AS groups cultured in the ALI medium devel-
oped the myofibroblast populations in a degree similar
to the cultures conducted in a standard HG medium
(Fig. 1a). Moreover, effectiveness of myofibroblastic tran-
sitions observed in the HBF AS populations was
significantly enhanced in contrast to the HBFs NA. The
immunofluorescent studies were confirmed by the meas-
urement of the α-SMA content incorporated into micro-
filaments (Fig. 1b) and the content of fibronectin (Fig.
1c) by in-cell ELISA tests. A distinct FMT potential of
both types of the HBFs observed at the protein levels
was confirmed also by RT-qPCR analyses of the FMT-
related gene expression, as ACTA2 (encoding α-SMA),
TAGLN (transgelin), FN1 (fibronectin) and TNC (tenas-
cin C). The TGF-β1-inducible expression of the FMT-
related genes in the HBF populations from AS or NA
cultured in HG or ALI medium was comparable (Fig.
1d). These data clearly indicate that the medium dedi-
cated for the ALI and EMTU cultures does not change
the HBFs properties and their FMT potential in response
to the TGF-β1 administration making it useful for the
EMTU experimental model.
EMTU cultures from asthmatics are more sensitive to the
TGF-β1 than non-asthmatic ones
Different properties of the normal and asthmatic HBFs
as well as the bronchial epithelium cultured independ-
ently in vitro were described previously [20, 31, 32]. In
this study, we checked the properties and sensitivity of
these cells from asthmatics and non-asthmatics growing
in co-cultures AS/AS and NA/NA in in vitro EMTU
model to the TGF-β1 (Fig. 2a). Firstly, we investigated
the integrity of the mucociliary differentiated HBECs
grown on Transwell inserts by the measurement of
transepithelial electrical resistance (TEER) [33, 34] be-
fore EMTU establishment. The TEER value was mea-
sured again in triplicates in each insert containing
differentiated HBECs cultured in the presence of HBFs
(in the EMTU) for 4 days. Our results presented as a
change in the TEER value in HBECs after EMTU estab-
lishment (after 4 days) in relation to the TEER values be-
fore EMTU establishment (control, in 0 day) show a
significant decrease of the TEER values in both types of
the EMTU (AS/AS and NA/NA) after the TGF-β1 treat-
ment (Fig. S1). However, the AS co-cultures are more
sensitive to the addition of exogenous TGF-β1 than the
NA ones (Fig. 2b). Next, we analyzed the effectiveness of
the FMT at the mRNA levels using RT-qPCR in HBF
populations cultured in the EMTU model after adminis-
tration of the TGF-β1. Our results revealed that the
HBFs AS show the enhanced level of ACTA2 (the main
marker of FMT) in the non-treated AS/AS EMTU in
comparison to the NA counterparts in co-cultures NA/
NA (Fig. 2c). Moreover, the expression of ACTA2 and
TAGLN increased significantly following stimulation
with the TGF-β1 only in the AS/AS EMTU co-culture
(Fig. 2c, d). Analyses of the fibronectin expression re-
vealed less spectacular differences between the HBFs
from AS and NA groups, but the trend showing the
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increased FMT-related genes and FMT potential in asth-
matics is maintained (Fig. 2e). Furthermore, we analyzed
the response of the mucociliary differentiated ALI cul-
tured HBECs to the addition of the exogenous TGF-β1.
While the expressions of dynein axonemal heavy chain 9
gene (DNAH9; Fig. 2f) in the epithelial layer of the AS/
AS EMTU co-cultures was similar to that of the NA/NA
counterparts, a significantly higher expression of mucin
5 AC gene (MUC5AC) was observed in the AS epithelial
layer in the control condition (Fig. 2g). The exogenous
TGF-β1 caused a significant decrease of the MUC5AC
expression only in the AS/AS EMTU (Fig. 2g) but had
no substantial effect on the expression of DNAH9 and
ACTA2 in the epithelial layer from both tested groups
(Fig. 2f, h). Because the TGF-β1 is known as a potent ac-
tivator of the EMT [10], we also analyzed the expression
of CDH2, SNAI1 and SNAI2 in the HBECs ALI cultures
in the EMTU model. TGF-β1-induced enhancement of
the mesenchymal marker CDH2 expression was signifi-
cantly higher in the AS epithelium in the AS/AS EMTU
than in the epithelial layer cultured in the NA/NA
EMTU (Fig. 2i). The baseline expression of the EMT-
related zinc finger transcription factors SNAI1 and
SNAI2 was comparable in both tested models, but insig-
nificant enhancement of these genes was observed in the
NA/NA EMTU after exposition to the TGF-β1 (Fig. 2j-
k). Our results indicate that the AS/AS EMTUs are more
sensitive to the TGF-β1 than NA/NA ones. It is associ-
ated with a higher potential of asthmatic co-cultures for
a profibrotic response, which is analogous to ‘2D’ stand-
ard in vitro cultures.
Mucociliary differentiated HBECs efficiently diminish the
TGF-β1–induced FMT potential in HBF populations
In the next step, we investigated the effect of ALI-
cultured mucociliary differentiated HBECs on the effi-
ciency of the TGF-β1-induced myofibroblastic transi-
tions of HBFs. Here, we analyzed the FMT potential of
HBFs in compatible (AS/AS, NA/NA) and mixed (AS/
NA, NA/AS) EMTU in comparison to the HBFs cul-
tured alone (in control conditions or in the presence of
the TGF-β1 (Fig. 3a). The exogenous TGF-β1 strongly
increased the expression of the FMT-related genes such
as ACTA2 (Fig. 3b), TAGLN (Fig. 3c) and FN1 (Fig. 3d)
in the HBFs AS. Effects of the TGF-β1 on the expression
of these genes in the HBFs NA were less evident, which
is in accordance with our previous observations in
standard ‘2D’ cultures [23, 26]. All the tested TGF-β1–
induced FMT-related genes in the HBFs AS were much
less expressed when cultured in the presence of
Fig. 1 Profibrotic response of TGF-β1-stimulated HBFs remains unchanged in ALI medium. HBFs derived from asthmatic patients and non-
asthmatic donors were cultured in HG medium or ALI medium in the absence (CTRL) or presence of TGF-β1 (5 ng/ml) for 4 days. Then, the FMT
potential of HBFs was determined by a immunofluorescence (Bar = 50 μm), b-c in-cell ELISA test (each condition in triplicates) and d RT-qPCR.
Expression of selected FMT-related genes: ACTA2 (α-smooth muscle actin), TAGLN (transgelin), FN1 (fibronectin) and TNC (tenascin C) was
calculated using GAPDH as a reference gene and presented as 2-ΔΔCt value. Data from all experiments represent the mean ± SEM carried out on
HBFs AS (n = 4) and NA (n = 4). Statistical significance was tested using the Kruskall-Wallis with Dunn’s Multiple Comparison post hoc test (the
comparison in one group). Statistical significance between tested groups (HBFs AS vs HBFs NA) was performed using the non-parametric
Friedmann with Dunn’s Multiple Comparison post hoc test; * p < 0.05, ** p < 0.01, *** p < 0.001
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mucociliary differentiated HBECs regardless their
phenotype. Noticeably reduced the ACTA2, TAGLN and
FN1 expression was observed in the TGF-β1-treated
HBFs AS when cultured in both the same-donor and
mixed EMTU (Fig. 3b - d). Similarly, the presence of
mucociliary differentiated HBECs in EMTU (AS/NA or
NA/NA) caused that the expression of ACTA2 and
TAGLN slightly enhanced by the TGF-β1 was reduced in
the HBF NA populations (Fig. 3b, c). However, the epi-
thelial layer had no effect on the FN1 expression in the
TGF-β1-treated HBFs NA (Fig. 3d). All together these
results suggest that the protective impact of
differentiated HBECs on the TGF-β1-induced myofibro-
blastic transitions is more pronounced in the HBFs AS
in comparison to the NA ones, probably due to the
higher responsiveness of HBFs AS to TGF-β1 than HBFs
NA under the mono-culture condition.
HBFs prevent destabilization of the TGF-β1-treated
mucociliary differentiated HBECs in the EMTU model
To check the effect of HBFs on the properties of differ-
entiated HBECs in the EMTU (Fig. 4a), we compared
tightness of the epithelial layer (Fig. 4b) and the expres-
sion of specific markers for the differentiated HBECs
Fig. 2 Asthmatic EMTUs are more sensitive on the TGF-β1 than non-asthmatic counterparts. a Mucociliary differentiated HBECs were cultured in
the presence of HBF populations for 4 days in EMTU model in the absence (CTRL) or presence of TGF-β1 (5 ng/ml). TEER values were measured
before EMTU establishment and after 4 days of cultures in triplicates for each experimental condition. b Results were presented as the change of
TEER value after 4 days of EMTU culture in relation to TEER values before EMTU establishment (% of control, where the control group was
compatible EMTU without the presence of TGF-β1) as an average ± SEM. Expression of selected c-e FMT- related genes: ACTA2 (α-smooth muscle
actin), TAGLN (transgelin), FN1 (fibronectin); f-g markers of mucociliary differentiated HBECs: DNAH9 (dynein axonemal heavy chain 9), MUC5AC
(mucin 5 AC) and h-k EMT-related genes: ACTA2, CDH2 (N-cadherin), SNAI1 (Snail) and SNAI2 (Slug) was measured by RT-qPCR and presented as
2-ΔCt value in relation to GAPDH as a reference gene. Data from all experiments represent the mean ± SEM carried out on HBFs AS (n = 4) and NA
(n = 4). Statistical significances were tested using the non-parametric Friedmann with Dunn’s Multiple Comparison post hoc test (comparison
between AS and NA group) or Kruskall-Wallis tests (comparison within the group) with Dunn’s Multiple Comparison post hoc test; * p < 0.05, **
p < 0.01,*** p < 0.001
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cultured alone and with the HBFs in the EMTU model
(Fig. 4c-e). We observed diminished TEER values in the
non-stimulated mucociliary differentiated HBECs AS in
comparison to the NA counterparts. The response of
ALI-differentiated HBEC populations to TGF-β1 admin-
istration was comparable in both tested groups (raw data
presented in Fig. S1). However, tightness of the differen-
tiated HBECs AS measured by TEER significantly in-
creased in the presence of the HBFs from AS group.
This effect was similar but less pronounced in the pres-
ence of the HBFs NA, but it was not observed in the dif-
ferentiated HBECs NA in co-cultures with the HBFs
derived from both study groups (Fig. 4b). Exposure of
the HBECs AS to the TGF-β1 in the HBFs AS presence
resulted in the reduction (c.a. 42%) of the TEER values,
which indicated an unsealed structure of tight junctions
in the AS epithelium (Fig. 4b). It was corresponding to
the reduced expression of DNAH9 and MUC5AC in this
arrangement (Fig. 4c, d). The effect of the TGF-β1 on
the epithelium tightness observed in the differentiated
HBECs AS cultured in the presence of the HBFs AS was
negligible, while in co-cultures of the differentiated
HBECs AS with the HBFs NA it was noteworthy (Fig.
4b). It indicates a different effect of the HBFs AS or NA
on the TEER values observed in the differentiated
HBECs AS. The presence of the HBFs AS or NA had no
significant effect on the DNAH9 expression in both types
of differentiated HBECs, but reduced the expression of
MUC5AC in the differentiated HBECs AS cultured with-
out the TGF-β1 (Fig. 4c, d). Expression of the basal cell
marker – p63 transcription factor was significantly in-
creased in the differentiated HBECs AS after the TGF-β1
treatment, but this effect was less pronounced in the
HBECs NA. Moreover, the TGF-β1-induced enhanced
expression of P63 was attenuated in both tested group of
the HBECs in the presence of the HBFs AS whilst the ef-
fect of HBFs NA was observed only in the TGF-β1-
treated HBECs AS (Fig. 4e).
Since the TGF-β1 is a well-known potent activator of
cellular differentiation including EMT in epithelial cells,
we investigated the expression of the EMT-related genes
in the EMTU model. As shown in Fig. 5, mucociliary
Fig. 3 The profibrotic response of TGF-β1-treated HBFs is diminished by mucociliary differentiated HBECs in EMTU co-cultures. a HBFs derived
from asthmatic patients (AS) and non-asthmatic donors (NA) were cultured alone (CTRL, TGF-β1) or in EMTU co-culture in the absence (CTRL
HBEC) or presence of TGF-β1 (5 ng/ml; TGF-β1 HBEC) for 4 days. Then, the FMT potential of HBFs was determined by RT-qPCR using GAPDH as a
reference gene. b-d ACTA2, TAGLN and FN1 (FMT-related genes) expression levels in HBFs were presented as 2-ΔΔCt value. Data from all
experiments represent the mean ± SEM carried out on HBFs AS (n = 4) and NA (n = 4). Statistical significances were tested using the non-
parametric Friedmann with Dunn’s Multiple Comparison post hoc test (comparison between AS and NA group) or Kruskall-Wallis tests
(comparison within the group) with Dunn’s Multiple Comparison post hoc test; * p < 0.05, ** p < 0.01,*** p < 0.001
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differentiated HBECs underwent the TGF-β1-induced
EMT characterized by the significant enhanced expres-
sion of mesenchymal markers, as CDH2, ACTA2, SNAI1
and SNAI2. The presence of the HBF populations from
both tested groups affected the responsiveness of the
HBECs AS to the TGF-β1 leading to noticeable reduc-
tion of the CDH2 expression (Fig. 5a) in a comparable
degree as in the HBECs NA. Similarly, the TGF-β1-in-
duced ACTA2 expression in the HBECs AS was signifi-
cantly attenuated in the EMTUs with the HBFs NA and
slightly weakened with the HBFs AS (Fig. 5b). The
ACTA2 expression was slightly expressed in the HBECs
NA in response to the TGF-β1. Therefore, the effect of
the HBFs presence was weaker. The TGF-β1-induced
significant enhancement of the SNAI1 expression was
observed in both the differentiated HBECs AS or NA
cultured alone. A noticeably diminished expression of
SNAI1 was observed only in the TGF-β1-treated differ-
entiated HBEC NA co-cultures with HBFs from both
study groups. However, the HBFs NA more effectively
reduced the SNAI1 expression than the AS ones (Fig.
5c). On the other hand, SNAI2 was expressed in re-
sponse to the TGF-β1 more efficiently in the HBECs AS
than in the NA counterparts. Therefore, the presence of
the HBF populations strongly affected the SNAI2 expres-
sion only in the AS HBECs (Fig. 5d). We also compared
Fig. 4 HBFs in EMTUs modulate the TEER value and ALI-related genes expression in AS epithelial layer. HBECs were cultured alone (CTRL, TGF-β1)
or in a EMTU co-cultures in the absence (CTRL HBFs) or presence of TGF-β1 (5 ng/ml; TGF-β1 HBFs) for 4 days. TEER values were measured before
EMTU establishment and after 4 days of cultures, in triplicates for each experimental condition. b Results were presented as the change of TEER
value after 4 days of EMTU in relation to TEER values before EMTU establishment (% of control, where the control group was the differentiated
HBECs cultured without the presence of HBFs AS or NA and TGF-β1) as an average ± SEM. c-d Expression of differentiated HBECs markers (DNAH9,
MUC5AC or P63) in EMTU was determined by RT-qPCR (reference: GAPDH c-d or GAPDH and 18S e). Results were presented as 2-ΔΔCt value. Data
from all experiments represent the mean ± SEM carried out on HBECs AS (n = 4) and NA (n = 4). Statistical significances were tested using the
non-parametric Friedmann with Dunn’s Multiple Comparison post hoc test (comparison between AS and NA group) or Kruskall-Wallis tests
(comparison within the group) with Dunn’s Multiple Comparison post hoc test; * p < 0.05, ** p < 0.01,*** p < 0.001
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the expression of SNAI1 to SNAI2 in our EMTU models.
We showed that in the TGF-β1-treated differentiated AS
HBECs cultured alone or in the presence of HBFs (AS
or NA) the SNAI1/SNAI2 ratio was comparable (Fig. 5e).
However, the SNAI1/SNAI2 ratio was meaningfully re-
duced in the populations of the TGF-β1-treated differen-
tiated HBECs NA when cultured in the presence of
HBFs from both study groups. Nevertheless, the HBFs
NA more strongly reduced the ratio than in case of the
AS ones (Fig. 5e). Our results indicate the protective ef-
fects of the HBFs on the structure of the TGF-β1–ex-
posed mucociliary differentiated HBEC populations and
their EMT potential.
Discussion
In the light of clinical relevance, the in vitro EMTU
model is much more accurate for conducting studies on
the complex mechanisms of airway remodeling since it
imitates in vivo-like conditions better than routinely
using the monocultures of bronchial fibroblasts or bron-
chial epithelial cells cultured in vitro. The EMTU model
was successively used in the studies on the interactions
between epithelium and fibroblasts from healthy donors
[35–37] or from donors with a diagnosed chronic lung
diseases [38, 39] including asthma [16–18]. Nonetheless,
until now the effect of the TGF-β1 on the structure and
function of the asthmatic or non-asthmatic EMTU has
been poorly described [35, 40]. Therefore, our study fills
this gap since we have demonstrated for the first time
that the asthmatic EMTUs (HBEC AS / HBF AS co-
cultures) show a distinct response to the TGF-β1 treat-
ment than the non-asthmatic ones and the effect of the
TGF-β1 on the FMT efficiency of HBFs and the EMT
potential in differentiated HBEC populations is weak-
ened when these cells were cultured in the EMTU
model. These results shed a new light on the Holgate’s
EMTU concept indicating a greater role of intrinsic
properties of HBFs in the regulation of the HBECs re-
sponsiveness to the TGF-β1 exposition as well as in
modulation of the pseudostratified epithelium structure
than previously thought [12, 41].
Comparison of the compatible asthmatic EMTU with
the non-asthmatic ones presented in our study revealed
more enhanced sensitivity to the TGF-β1 of the AS co-
cultures than in case of the NA ones. Measurement of
TEER determines the quality of the differentiated pseu-
dostratified airway epithelium with well-developed tight
junctions, and is often used as an epithelium barrier
function marker [33, 34, 42, 43]. However, differences in
the TEER values between ALI monocultures of asth-
matic and non-asthmatic HBECs remain contradictory
[44–47]. Our study revealed increased values of TEER in
Fig. 5 HBF populations in EMTU co-cultures protect the ALI-cultured HBECs against the potent TGF-β1 influence. HBECs were cultured alone or in
EMTU in the absence (CTRL) or presence of TGF-β1 (5 ng/ml) for 4 days. Then, the expression of EMT-related genes: a CDH2 (N-cadherin), b ACTA2,
c-d SNAI1 and SNAI2 were determined by RT-qPCR using GAPDH as a reference gene and presented as 2-ΔΔCt values. e SNAI1/SNAI2 ratio was
calculated and presented. Data from all experiments represent the mean ± SEM carried out on HBECs AS (n = 4) and NA (n = 4). Statistical
significances were tested using the non-parametric Friedmann with Dunn’s Multiple Comparison post hoc test (comparison between AS and NA
group) or Kruskall-Wallis with Dunn’s Multiple Comparison post hoc test (comparison within each group); * p < 0.05, ** p < 0.01,*** p < 0.001
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the non-stimulated ALI cultures of the HBECs NA in
comparison to the AS counterparts. The HBFs presence
in compatible EMTUs in the AS co-cultures strongly af-
fects the TEER values in contrast to the NA compatible
EMTUs. However, after the TGF-β1 stimulation of co-
cultures, the AS EMTUs were characterized by a greater
decrease of TEER than the NA ones, which indicated
that the reaction of the AS differentiated HBECs to the
TGF-β1 was intensified compared to the NA counter-
parts. Moreover, our study showed the enhanced TEER
in the AS differentiated HBECs cultured in the presence
of the HBFs regardless of their origin (AS or NA). The
co-cultures of the HBFs with the HBECs NA slightly af-
fected the TEER values. However, only the HBFs NA in
the mixed TGF-β1 treated EMTU cultures showed a no-
ticeable protective effect of the HBFs on the epithelial
layer permeability (measured as the TEER value). A
similar protective effect of fibroblasts on the TEER
values was described previously in co-cultures of the
HBECs with MRC5 cells in the EMTU model compared
to equivalent HBEC monocultures [48].
Longitudinal studies on the TGF-β1-induced FMT po-
tential (a key event in asthmatic subepithelial fibrosis)
revealed a facilitated ability of the asthmatic HBF popu-
lations in standard ‘2D’ cultures for phenotypic shifts
[23, 25, 27, 28, 30, 49], that may indicate the involve-
ment of intrinsic properties of these cells in the regula-
tion of FMT. In this study, we also observed the
enhanced FMT potential in the TGF-β1-simulated HBF
AS populations in contrast to the NA counterparts,
when cells were grown in a monoculture as well as in
compatible EMTUs. Moreover, a slightly larger decrease
of the ACTA2 expression was observed in the TGF-β1-
treated HBFs AS after mixing EMTUs with the HBECs
NA than in compatible counterparts. It indicates a pro-
tective effect of the non-asthmatic HBECs on the FMT
potential in airway fibroblast populations which was pre-
viously reported by Reeves et al., [16, 17] in non-
stimulated human lung fibroblasts. A substantial de-
crease of the TAGLN expression was observed in the
TGF-β1-simulated HBFs AS cultured in the compatible
and mixed EMTU and in the TGF-β1-simulated HBFs
NA cultured in the compatible EMTU, but not in the
EMTU with the HBECs AS. It suggests that the intrinsic
properties of HBECs AS may stimulate the profibrotic
response of HBFs NA. On the other hand, noticeable
downregulation of the FN1 expression analyzed in the
TGF-β1-simulated AS HBFs after mixed and compatible
EMTUs were carried out, was observed. However, a
slightly increased expression of FN1 was detected in the
TGF-β1-simulated HBFs NA after mixed EMTU which
may indicate that these interrelations between the tested
cells affect the ECM protein production (FN1). A similar
observation was described by Reeves et al., [18], where
human lung fibroblasts from healthy donors expressed
enhanced levels of FN1 when cultured in the HBECs AS.
Therefore, our results showed that the more effective
FMT observed in the HBF AS populations can be con-
sidered as a universal and repetitive phenomenon in dif-
ferent types of ‘2D’ or 3D cultures and may be affected
by the presence of both humoral stimuli such as the
TGF-β1, and interrelations of fibroblasts with the airway
epithelium.
Differences between the asthmatic and non-asthmatic
ALI-cultured pseudostratified HBECs have been also
compared in these studies. We did not observe any sig-
nificant differences at the mRNA level in the expression
of DNAH9 and MUC5AC between the differentiated
HBECs AS and NA. However, we observed a slightly en-
hanced expression of DNAH9 and notably increased ex-
pression of MUC5AC in the AS/AS EMTUs in
comparison to the NA/NA EMTUs. Similar results that
reported defective mucociliary clearance in asthmatics
were observed previously [50–52]. The up-regulation of
another marker of the basal cells subpopulation in the
TGF-β1-treated pseudostratified epithelium – P63 en-
hanced in the HBECs AS in comparison to NA, observed
in our study, was diminished by the presence of the
HBFs. The recent studies suggest that p63+ basal cells
with stem cell-like properties are also involved in the in-
duction and/or regulation of EMT significantly enhanced
in asthmatic patients [31, 53] which remains in accord-
ance with our observations.
Exposition of HBECs in monocultures or in AS
EMTUs to the TGF-β1 insignificantly decreased the ex-
pression of the tested markers in subpopulations of dif-
ferentiated HBECs leading to impairment of the barrier
function of epithelium which complies with the previous
reports [37, 40]. In the pseudostratified monocultures of
the HBECs we observed the TGF-β1–induced EMT pro-
gram described in lung fibrosis leading to the enhance-
ment of the expression of mesenchymal genes as
ACTA2, CDH2 and EMT-related transcription factors
SNAI1 and SNAIL2 [10, 31, 40, 54, 55]. A strong
mesenchymal-like phenotype of the TGF-β1-stimulated
HBECs AS was characterized by relatively high levels of
mesenchymal markers (CDH2+and ACTA2+) and SNAI1
and SNAI2 expression (at a ratio ca. 2:1). However, when
the pseudostratified TGF-β1-stimulated HBECs AS were
co-cultured with HBFs, the expression of mesenchymal
markers and SNAI2 was noticeably reduced, but the
SNAI1/SNAI2 ratio remains comparable to the ratio ob-
served in monocultures of the HBECs AS.
The recent reports have suggested that SNAI1 prefera-
bly regulates α-SMA whereas SNAI2 affects the
epithelial-related genes [56]. Overexpression of SNAI2
led to downregulation of E-cadherin and occludins in
the HBECs, whereas overexpression of SNAI1 to the
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enhanced α-SMA expression [40]. The elevated level of
SNAI1 leading to enhancement of α-SMA with the con-
comitantly enhanced expression of SNAI2 which down-
regulates the epithelial genes led to the efficient EMT of
epithelial cells. However, a disturbed balance in the
SNAI1/SNAI2 ratio in conjunction with the function of
P63 may lead to incomplete EMT. In our study the
TGF-β1-stimulated ALI-cultures of HBECs AS are char-
acterized by the low SNAI1/SNAI2 ratio with relatively
high levels of the mesenchymal gene expression, whereas
the HBECs NA showed an increase of this ratio and a
relatively low expression of ACTA2 with high CDH2.
Johnson et al., [40] described a similar observation,
where a relatively high ratio of SNAI1/SNAI2 was ob-
served in the HBECs from healthy donors (ca. 14), but
in the HBECs isolated from mild and severe asthmatic
patients it was significantly decreased (ca. 6.6 and 5.0 re-
spectively) with a concomitant relatively high level of
CDH2 in all tested groups. Surprisingly, the SNAI1/
SNAI2 ratio in the TGF-β1-treated HBECs AS co-
cultured with HBFs in the EMTU was comparable to the
ratio in the TGF-β1-treated monocultures, but mesen-
chymal markers were significantly diminished in these
cells. It suggests that not only the SNAI1/SNAI2 ratio is
involved in the EMT by modulation of the HBECs re-
sponsiveness to the TGF-β1, but also the HBFs intrinsic
properties may have a protective effect on the HBECs
reactivity. Despite that, our hypothesis requires further
research to show which features of HBFs may have a sig-
nificant effect on the EMT potential of the bronchial
HBECs cultured in the EMTU.
Conclusions
Functional interactions between HBECs and HBFs
within the epithelial-mesenchymal trophic unit are
necessary for a proper functioning of lung tissue.
EMTU of HBECs and HBFs derived from AS patients
and NA donors were established in this study. The
effects of the TGF-β1 on the properties of HBECs
cultured in the air-liquid-interface and effectiveness of
FMT in HBFs in the EMTU models from both stud-
ied groups were compared and analyzed for the first
time. Our results are the first to show that the AS
co-cultures are more sensitive to the TGF-β1 than the
NA ones. Our data also demonstrated a protective ef-
fect of HBFs on the properties of HBECs, which sug-
gested that intrinsic properties of not only epithelium
but also subepithelial fibroblasts affected a proper
condition and function of the EMTU in both normal
and asthmatic individuals. Our study suggests that
EMTU AS and NA systems will be important tools
for studying the mechanisms of subepithelial fibrosis
in asthma, as well as for drug screening.
Methods
Patients characteristics
All patients were treated in the Faculty of Medicine of
the Jagiellonian University Medical College, Krakow,
Poland, and were in stable clinical conditions. The ex-
perimental group consisted of 4 patients with moderate
asthma [Global Initiative for Asthma (GINA) grade 3–4;
4 females, age (years): 50.2 ± 18.7; BMI (kg/m2): 28.9 ±
4.0; FEV1 (% predicted): 107 ± 20.9; FEV1/FVC (%):
76.5 ± 7.15; iGCS (inhaled glucocorticoids; fluticasone)
and long-acting beta agonists (LABAs); 4/4]. The control
group of 4 non-asthmatic patients in whom diagnostic
bronchoscopy ruled out any serious airway pathology [4
females, age (years): 40.5 ± 17.21; BMI (kg/m2): 26.6 ±
3.1; FEV1 (% predicted): 106.45 ± 9.42; FEV1/FVC (%):
81.11 ± 4.10]. The control subjects were referred for
bronchoscopy due to diagnosis of cough, as a part of
routine investigation. All controls were non-allergic, had
normal lung function tests. Additionally, respiratory
tract disorders (e.g. asthma, sarcoidosis, interstitial lung
disease, COPD, lung cancer, etc.) were further ruled out
during clinical investigation (e.g. no pathology in airway
biopsy or CT scan). All study participants were non-
smokers. The study was approved by the Jagiellonian
University Ethics Committee (Decision No.
122.6120.16.2016; 22 January 2019) and informed writ-
ten consent was obtained from all participants.
HBFs cultures
Primary cultures of HBFs were isolated from bronchial bi-
opsies derived from patients with diagnosed asthma (AS)
and from non-asthmatic donors (NA) according to the
protocols described previously [57]. HBFs were cultured
in complete medium: Dulbecco’s Modified Eagle Medium
(DMEM) with high glucose (4500mg/L glucose; HG) sup-
plemented by 10% fetal bovine serum (FBS, Gibco) and
1% penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO,
USA) in standard conditions (37 °C, humidified atmos-
phere, 5% CO2). Cells between 5
th–10th passages were
used in the experiments. HBFs were plated at a density of
5000 cells/cm2 in complete medium for 24 h. Afterwards
cells were incubated for the next 24 h in the serum-free
medium: DMEM HG supplemented with 0.1% bovine
serum albumin (BSA, Sigma-Aldrich) or in the medium
dedicated for air-liquid interface (ALI) cultures (ALI
medium; 1:1 mixture of Bronchial Epithelial Basal
Medium (BEBM) and DMEM supplemented by BEGM™
SingleQuots™ Supplement Pack, Lonza). When indicated,
the human recombinant TGF-β1 (5 ng/mL, stock prepared
in 1mg/mL BSA/PBS) was added.
Mucociliary differentiation of HBECs
After isolation from bronchial biopsies derived from the
AS patients and NA donors described previously [29],
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HBECs were seeded onto collagen-coated flasks and cul-
tured to ca. 90% confluence in Bronchial Epithelial
Growth Medium (BEGM; BEBM with supplements).
Then, cells were passaged and transferred onto collagen-
coated Transwell polycarbonate inserts (0.4-mm pore
size; Corning) at a density of 1.3–1.5 × 105 cells/cm2 in
BEGM. Next day, the medium from HBECs was re-
moved and the medium below inserts was replaced by
the ALI medium with all-trans-retinoic acid (50 nM;
Sigma-Aldrich). The cells were cultured in the air-liquid
interface (ALI) for 30 days (Fig. 6) to obtain a pseudos-
tratified epithelium containing ciliary (DNAH9-positive)
and goblet cells (MUC5AC-positive).
Epithelial-mesenchymal trophic unit model
HBFs were seeded into 12-well plates in a complete
medium. Next day the medium was replaced by the
fresh ALI medium and inserts with the mucociliary dif-
ferentiated HBECs were transferred into appropriate
wells (in combinations as in Fig. 6b). The EMTU cul-
tures were exposed to the TGF-β1 and cultivated by 4
days (Fig. 6a). A profibrotic response of HBECs and
HBFs on the TGF-β1 was analyzed by RT-qPCR, im-
munofluorescence and/or in-cell ELISA assay.
Transepithelial electrical resistance (TEER) measurements
A fresh medium was added to the ALI-cultured
HBECs to the upper part of inserts and TEER was
measured as described previously [33, 34] using Milli-
cell ERS-2 Voltohmmeter (Merck Millipore) each in
triplicates. Results were presented as a change in
TEER values (Ω x cm2) in the mucociliary differenti-
ated HBECs after 4 days of the EMTU as a percent-
age of control, where the control was the same well
before the EMTU establishment (Ω x cm2 after
EMTU/Ω x cm2 before EMTU)*100%.
Analyses of α-SMA intracellular localization and content
For immunofluorescent studies, the HBFs growing on
coverslips were fixed with 3.7% formaldehyde/PBS,
permeabilized with 0.1% Triton X-100/PBS and blocked
with 3% BSA/PBS. Immunostaining of α-SMA was per-
formed using primary anti-α-SMA antibody (mouse
monoclonal IgG, A2547, clone 1A4, 1:400, Sigma-
Aldrich) and compatible goat anti-mouse secondary IgG
antibody conjugated with Alexa Fluor 488 (1:500,
Thermo Fisher) with Hoechst 33258 (1 μg/mL, Sigma-
Aldrich) for cell nuclei detection. Slides were mounted
in the fluorescence mounting medium (DAKO) and vi-
sualized by automatic fluorescent microscope Leica
DMI6000B (Leica Microsystems, Wetzlar, Germany),
equipped with the LAS-X software, all at the same fluor-
escent time exposure. For the cell-based enzyme-linked
immunosorbent (in-cell ELISA) analyses of the α-SMA
and fibronectin (using a primary rabbit polyclonal anti-
body, F3648; 1:2000; Sigma-Aldrich) content, methanol-
fixed HBFs were prepared according to the protocol de-
scribed previously [57]. Results were presented as ab-
sorbance values measured at 450 nm by Microplate
Reader (Thermo Fisher Scientific).
Real-time quantitative PCR
After 4 days of the EMTU (as depicted in Fig. 1a-b), both
types of cells were collected separately and the total
mRNA was isolated according to the manufacturer’s
protocol using the RNAx/miRNA GeneMATRIX UNI-
VERSAL purification kit (E3599–02, EURx). Afterwards,
the reverse transcription reaction carried out using the
NG dART RT-PCR Kit (E0801–02; EURx), 150 ng cDNA
was used for further analyses. Expression of genes was
performed using a real-time polymerase chain reaction
(RT-qPCR, real-time PCR) with SYBR™ Green PCR Mas-
ter Mix (Applied Biosystems, Thermo Fisher Scientific)
and designed specific primers (Table 1). Results were
presented as the 2-ΔΔCt or 2-ΔCt value ± SEM.
Fig. 6 Schematic illustration of a the EMTU establishment and b all used cell combinations
Paw et al. BMC Molecular and Cell Biology           (2021) 22:19 Page 11 of 14
Statistics
Data are presented as a mean ± SEM. Statistical signifi-
cances the non-parametric Friedmann with Dunn’s Mul-
tiple Comparison post hoc test: * p < 0.05, ** p < 0.01, ***
p < 0.001 (the comparison between the tested AS and
NA group) or the Kruskall-Wallis with Dunn’s Multiple
Comparison post hoc test (the comparison within the
group): * p < 0.05, ** p < 0.01, *** p < 0.001. The statistical
analyses were performed using GraphPad Prism 5.0
software.
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Table 1 Primers sequences
GENE SEQUENCE
ACTA2 F′ CTGTTCCAGCCATCCTTCAT R’ CCGTGATCTCCTTCTGCATT
DNAH9 F′ GAGTCTTCCCAGCCACTCTTAC R’ ATTCTGCATTCTCCAGAGCTTC
GAPDH F′ GAAGGTGAAGGTCGGAGT R’ GAAGATGGTGATGGGATTTC
MUC5A F′ TTCCATGCCCGGGTACCTG R’ CAGGCTCAGTGTCACGCTCTT
CDH2 F′ CTCCATGTGCCGGATAGC R’ CGATTTCACCAGAAGCCTCTAC
P63 F′ CCCGTTTCGTCAGAACACAC R’ CATAAGTCTCACGGCCCCTC
SNAI1 F′ GCTGCAGGACTCTAATCCAGA R’ ATCTCCGGAGGTGGGATG
SNAI2 F′ TGGTTGCTTCAAGGACACAT R’ GTTGCAGTGAGGGCAAGAA
FN1 F′ TGTGGTTGCCTTGCACGAT R’ GCTTGTGGGTGTGACCTGAGT
TAGLN F′ CGTGGAGATCCCAACTGGTT R’ AAGGCCAATGACATGCTTTCC
TNC F′ GGTCCACACCTGGGCATTT R’ TTGCTGAATCAAACAACAAAACAGA
18S F′ GTAACCCGTTGAACCCCAT R’ CCATCCAATCGGTAGTAGCG
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